Literature DB >> 18647283

Incidence and case fatality for acute pancreatitis in England: geographical variation, social deprivation, alcohol consumption and aetiology--a record linkage study.

S E Roberts1, J G Williams, D Meddings, M J Goldacre.   

Abstract

BACKGROUND: Regional studies in the UK indicate that the incidence of acute pancreatitis increased from the 1940s to the 1990s, while case fatality fell until the 1970s but has levelled-off since. AIMS: To establish incidence and case fatality for acute pancreatitis in England from 1998 to 2003, to study geographical variation and recent trends in incidence and to study associations with social deprivation and alcohol consumption.
METHODS: Use of national record linkage of in-patient and mortality data for 52 096 people.
RESULTS: Overall incidence was 22.4 per 100 000 population, increasing by 3.1% annually, with largest increases for women aged under 35 years (11% per year) and for men aged 35 to 45 (5.6%). Incidence was higher in northern regions than in southern regions and in areas with high social deprivation and binge drinking. Case fatality was 6.7% at 60 days, higher for alcoholic than gallstones aetiology and was associated with social deprivation and geography.
CONCLUSIONS: Acute pancreatitis is a growing problem in England, particularly among younger women. The findings indicate strongly that alcohol consumption is the main reason for recent increases in incidence, the higher incidence in socially-deprived areas and for the lack of recent improvement in prognosis.

Entities:  

Mesh:

Year:  2008        PMID: 18647283     DOI: 10.1111/j.1365-2036.2008.03809.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  25 in total

1.  Hospital episode statistics: time for radical change.

Authors:  J G Williams; I Carpenter
Journal:  Clin Med (Lond)       Date:  2012-02       Impact factor: 2.659

2.  Pancreas: A new model to predict mortality in acute pancreatitis.

Authors:  Albert B Lowenfels; Patrick Maisonneuve
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

3.  Natural history of acalculous biliary symptoms.

Authors:  A M Warwick; F Bintcliffe; E Wu; D Stell
Journal:  Ann R Coll Surg Engl       Date:  2013-10       Impact factor: 1.891

4.  Monitoring clinical activity and performance: how can hospital episode statistics be made fit for purpose?

Authors:  John G Williams
Journal:  Frontline Gastroenterol       Date:  2011-03-31

Review 5.  Development of an integrated pancreatic disease service.

Authors:  James A Jupp; Colin D Johnson; Fanny W Shek; David R Fine
Journal:  Frontline Gastroenterol       Date:  2011-01-09

6.  Feasibility of using routinely collected inpatient data to monitor quality and inform choice: a case study using the UK inflammatory bowel disease audit.

Authors:  Stephen E Roberts; John G Williams; David R Cohen; Ashley Akbari; Sam Groves; Lori A Button
Journal:  Frontline Gastroenterol       Date:  2011-04-05

7.  Analyses of hospital administrative data that use diagnosis codes overestimate the cases of acute pancreatitis.

Authors:  Shreyas Saligram; David Lo; Melissa Saul; Dhiraj Yadav
Journal:  Clin Gastroenterol Hepatol       Date:  2012-04-10       Impact factor: 11.382

8.  Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs: a population-based cohort study.

Authors:  Antonio Gonzalez-Perez; Raymond G Schlienger; Luis A García Rodríguez
Journal:  Diabetes Care       Date:  2010-09-10       Impact factor: 19.112

Review 9.  The changing character of acute pancreatitis: epidemiology, etiology, and prognosis.

Authors:  Albert B Lowenfels; Patrick Maisonneuve; Thomas Sullivan
Journal:  Curr Gastroenterol Rep       Date:  2009-04

10.  Incidence and mortality of acute and chronic pancreatitis in the Netherlands: a nationwide record-linked cohort study for the years 1995-2005.

Authors:  B W Marcel Spanier; Marco J Bruno; Marcel G W Dijkgraaf
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.